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Background: Nox4-derived ROS is required for Src oxidation and activation.
Results:Grb2 recruitsNox4 to the scaffold protein SHPS-1, andNox4 colocalizationwith Src on SHPS-1 allowsNox4 to activate
Src.
Conclusion: Nox4 recruitment to SHPS-1 is essential for sustained Src activation and cell proliferation.
Significance: This is the first report that localized ROS generation mediates growth factor signaling in vitro and in vivo.
Nox4-derived ROS is increased in response to hyperglycemia
and is required for IGF-I-stimulated Src activation. This study
was undertaken to determine the mechanism by which Nox4
mediates sustained Src activation. IGF-I stimulated sustained
Src activation, which occurred primarily on the SHPS-1 scaffold
protein. In vitro oxidation experiments indicated that Nox4-de-
rived ROS was able to oxidize Src when they are in close prox-
imity, and Src oxidation leads to its activation. Therefore we
hypothesized that Nox4 recruitment to the plasma membrane
scaffold SHPS-1 allowed localized ROS generation to mediate
sustained Src oxidation and activation. To determine themech-
anismofNox4 recruitment,we analyzed the role ofGrb2, a com-
ponent of the SHPS-1 signaling complex. We determined that
Nox4 Tyr-491 was phosphorylated after IGF-I stimulation and
was responsible for Nox4 binding to the SH2 domain of Grb2.
Overexpression of a Nox4 mutant, Y491F, prevented Nox4/
Grb2 association. Importantly, it also prevented Nox4 recruit-
ment to SHPS-1. The role of Grb2 was confirmed using a Pyk2
Y881F mutant, which blocked Grb2 recruitment to SHPS-1.
Cells expressing this mutant had impaired Nox4 recruitment to
SHPS-1. IGF-I-stimulated downstream signaling and biological
actions were also significantly impaired in Nox4 Y491F-overex-
pressing cells. Disruption of Nox4 recruitment to SHPS-1 in
aorta from diabetic mice inhibited IGF-I-stimulated Src oxida-
tion and activation as well as cell proliferation. These findings
provide insight into the mechanism by which localized Nox4-
derived ROS regulates the sustained activity of a tyrosine kinase
that is critical for mediating signal transduction and biological
actions.
The generation of cellular reactive oxygen species (ROS)2 has
been shown to influence cell proliferation, migration, apopto-
sis, and the progression of various diseases (1). However, previ-
ous clinical trials have failed to show antioxidants that suppress
the generalized increase of cellular ROS reduce the risk and/or
progression of atherosclerosis (2) or metabolic syndrome (3).
Two recent studies have suggested that localization of ROS
generation in a specific subcellular compartment can regulate
cellular signaling and biological functions. Inactivation of
membrane-associated peroxiredoxin I led to local accumula-
tion ofH2O2,whichwas required for healing cutaneouswounds
(4). In another study, NADPH oxidase 2 (Nox2) was found to
localize in the leading edge of lamellipodial focal complex, and
this was shown to play a role in endothelial cell migration (5).
In vascular cells, Noxs are the major sources of cellular ROS
(6), and in vascular smooth muscle cells (VSMC), Nox1 and
Nox4 are the major isoforms (7). Nox4-derived ROS has been
shown to be required for angiotensin II- (8) and IGF-I-stimu-
lated Src activation (9). Differential subcellular localization of
Nox4 has been correlated with alteration in specific cellular
functions. For instance, endoplasmic reticulum localization of
Nox4 has been shown to regulate protein tyrosine phosphatase
1B-mediated alterations in EGF signaling (10). Mitochondrial
localized Nox4 has been shown to mediate high glucose-in-
duced ROS generation (11), and vinculin-colocalizedNox4 was
shown to play an important role in mediating focal adhesion
formation (12). However, only one of these studies (10) showed
an alteration in a signal pathway that was dependent upon
Nox4 oxidation of a specific target protein, and that study did
not determine the significance of the change in vivo.
Our previous studies have shown that SHPS-1, a plasma
membrane protein, functions as a localized scaffold for the for-
mation of a signaling complex, which is required for mediating
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to hyperglycemia (13, 14). This complex includes Src, and
SHPS-1-localized Src plays an essential role in mediating IGF-I
actions (15). Using unbiased mRNA display, we showed that
Nox4 associated with SHPS-1 in response to IGF-I stimulation
(14). However, the biological consequences and underlying
mechanism of Nox4 recruitment to SHPS-1 have not been
investigated. Because Nox4-derived ROSmediates IGF-I-stim-
ulated Src oxidation and activation (9), we hypothesized that
recruitment ofNox4 and Src to SHPS-1 results in localizedROS
generation, which is required for oxidation of Src and its sus-
tained activation. Furthermore, we determined how Nox4 is
recruited to SHPS-1 in response to IGF-I stimulation in VSMC
and the consequences of disruptionNox4 recruitment for IGF-I
signaling and biological actions in vivo.
EXPERIMENTAL PROCEDURES
Human IGF-I was a gift from Genentech (South San Fran-
cisco, CA). Immobilon-P membranes, anti-2,4-dinitrophenyl,
and Src antibodies were purchased from Millipore Corp. (Bil-
lerica, MA). DMEM containing 4500 and 1000 mg of glucose/
liter, streptomycin, and penicillin were purchased from Invit-
rogen. Grb2 and caveolin antibodies were purchased from BD
Bioscience (San Diego, CA). Antibodies against phospho-AKT
(Ser-473), total AKT, phospho-Src (Tyr-419), phospho-Erk1/2
(Thr-202/Tyr-204), total Erk1/2, and HA were from Cell Sig-
naling Technology Inc. (Beverly, MA). Anti-phosphotyrosine
(Tyr(P)-99), p22phox, and -actin antibodies were purchased
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-
Nox4 and prohibitin antibodies were purchased from Abcam
Inc. (Cambridge, MA). SHPS-1 polyclonal antiserum was pre-
pared as described previously (16). The horseradish peroxi-
dase-conjugated mouse anti-rabbit, goat anti-mouse, and
mouse anti-rabbit light chain-specific antibodies were pur-
chased from Jackson ImmunoResearch Laboratories (West
Grove, PA).All other reagentswere obtained fromSigmaunless
otherwise stated. A synthetic peptide was prepared that con-
tained the TAT sequence that confers cell permeability fol-
lowed by a YVNI-containing sequence (underlining indicates
residues 486–496 inNox4 except that Tyrwas substitutedwith
Asp) YARAAARQARAENRPDDVNIQL. A peptide containing
a scrambled sequence (YARAAARQARAEDNPRFNQLVI)
was synthesized to serve as a control peptide. In this peptide,
the Tyr was substituted with Phe. The peptides were synthe-
sized by the ProteinChemistryCore Facility at theUniversity of
North Carolina at Chapel Hill. The sequences were verified by
mass spectrometry.
Cell Culture—VSMCwere isolated fromporcine aortas using
a method described previously (17). The cells were maintained
inDMEMcontaining high glucose (25mM glucose) and supple-
mented with 10% fetal bovine serum (Hyclone, Logan, UT),
streptomycin (100 g/ml), and penicillin (100 units/ml). The
cells were used between passages 5 and 15.
Construction of cDNAs and Establishment of VSMC Express-
ingWild Type Nox4, Nox4 Y491F,Wild Type Pyk2, Pyk2 Y881F,
Wild Type SHPS-1, SHPS-1 Cytoplasmic Domain-deleted, and
Mitochondria-localized Catalase Cells—Wild type human
Nox4 cDNA contained in the pCMV-SPORT6 vector was pur-
chased from Thermo Fisher Scientific (Huntsville, AL). PCR
with the forward and reverse primers 5-caccatggctgtgtcctg-
gaggagctg-3 and 5-ttaAGCGTAATCTGGAACATCGTAT-
GGGTAgctgaaagactctttattg-3 was used to prepare the full-
length cDNA. The PCR product contained a Kozak sequence
(CACC) at the 5 end and a HA sequence (capitalized) at the 3
end. Wild type Nox4 cDNA was used as a template to generate
a cDNA encoding Nox4 Y491F. The forward and reverse prim-
ers that were used were: 5-gaacagacctgactTtgtcaacatccagct-
g-3 and 5-cagctggatgttgacaAagtcaggtctgttc-3. The und-
erlined bases indicate the substitutions that changed tyrosine
491 to phenylalanine. Point mutations were introduced using a
standard protocol (QuikChange; Stratagene, La Jolla, CA). Mi-
tochondria-localized catalase cDNA was obtained from
pCAGGS (a gift from Dr. Robinovitch, University of Washing-
ton). PCR was used to add the HA tag and a Kozak sequence
with the following forward and reverse primers: 5-caccatgctg-
tttaatctgaggatcctg-3 and 5-ttaAGCGTAATCTGGAACATC-
GTATGGGTAatccggactgcacaaaggtg-3. That the constructs
contained the correct sequences was verified by DNA sequen-
cing. 293FT cells (Invitrogen) were prepared for generation of
virus stocks, and VSMC expressing Nox4, Nox4 Y491F, and
mitochondria-localized catalase were established using proce-
dures that were described previously (18). VSMC expressing
wild type Pyk2, Pyk2 Y881F, wild type SHPS-1, and cytoplasmic
domain-deleted SHPS-1,were prepared as described previously
(14, 19).
Isolation Cytoplasmic and Membrane Fraction Proteins—
The cells were grown to confluence and were serum-starved
16 h before IGF-I treatment. After IGF-I stimulation for the
indicated times, membrane and cytoplasmic fractions proteins
were isolated following a procedure described previously (18).
Immunoprecipitation, Double Immunoprecipitation, and
Immunoblotting—The cellmonolayerswere lysed in amodified
radioimmunoprecipitation assay buffer as described previously
(18). Immunoprecipitation was performed by incubating 0.5
mg of cell lysate protein with 1 g of each of the following
antibodies: anti-Src, SHPS-1, Nox4, and HA at 4 °C overnight.
Double immunoprecipitationwas performedusing a procedure
described previously (19). Briefly, the first round immunopre-
cipitation was performed with an anti-Nox4 antibody or a non-
immune IgG (control). The beads were resuspended in 30 l of
SDS buffer (20mMTris, pH 7.5, 50mMNaCl, 2% SDS) contain-
ing 1mMDTT.The resuspended supernatantwas added to cold
radioimmunoprecipitation assay buffer (final concentration,
0.1% SDS), incubated overnight, and then used for a second
immunoprecipitation with an anti-Src antibody (1: 500 dilu-
tion). The second immunoprecipitationwas followed by immu-
noblotting that was performed as described previously (18)
using a dilution 1:1000 for anti-pAKT (Ser-473), AKT, 2,4-di-
nitrophenyl, pSrc (Tyr-419), Src, SHPS-1, pErk1/2 (Thr-202/
Tyr-204), Erk, and -actin antibodies, a dilution of 1:500 for an
anti-Nox4 antibody, and a dilution of 1:5000 for anti-Grb2 anti-
body. The proteins were visualized using enhanced chemilumi-
nescence (Thermo Fisher Scientific). Total cellular protein in
the lysates was determined using BCA (Thermo Fisher
Scientific).
In Vitro Binding Assay—The in vitro [35S]methionine (MP
Biomedical, Solon, OH) labeled wild type Nox4 was generated
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by a transcription/translation (TNT) reaction (Promega, Madi-
son, WI). An aliquot of the TNT mixture (0.4 M total protein)
was incubated with 200 ng of purified active Src (Millipore,
Billerica, MA) in binding buffer (HEPES, pH 7.6, 50 mM KCl, 1
mMDTT, 0.5 mM PMSF, 0.2% Triton X-100, and 10% glycerol),
using a 100-l final volume for 2 h at 4 °C. 0.5 g of anti-Src
antibody and 30 l (50% slurry) of protein A/G-agarose beads
were added and incubated for 2 h at 4 °C. After extensive wash-
ing with the binding buffer, the precipitated proteins were
eluted in 30 l of 2 Laemmli sample buffer, boiled for 5 min,
and separated using 10% SDS-PAGE. The images were devel-
oped and analyzed using a Storm860 phosphorus imager (GE
Healthcare). For Nox4/Grb2 or SHP-2 binding assays, TNT
expressedNox4WTorNox4Y491F (100 ng each)was enriched
by immunoprecipitating with an anti-Nox4 antibody and phos-
phorylated by active Src (150 unit) in a buffer containing 50mM
HEPES-NaOH (pH 7.6), 3 mM MnCl2, 10 mM MgCl2, 0.1 mM
EGTA, 1 mM dithiothreitol, 0.1 mM Na3O4, and 0.2 mM ATP
and incubating at 30 °C for 30 min. After extensive washing
with the above buffer, purified SHP2 (Millipore, Billerica, MA;
500 ng) or Grb2 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA; 500 ng) was added and incubated for 2 h at 4 °C in the
binding buffer (500 l). After extensive washing with the bind-
ing buffer, the precipitated proteins were separated using 10%
SDS-PAGE and immunoblotted with an anti-Grb2 or SHP2
antibody, respectively.
InVitro Src ProteinOxidationAssay andH2O2Measurement—
Nonoxidized Src was prepared from quiescent VSMC cultured
in DMEM containing normal glucose (5 mM) by immunopre-
cipitating with an anti-Src antibody (1:500 dilution). The acti-
vated Nox4/p22phox enzymatic complex was prepared from
VSMC cultured in DMEM containing high glucose (25 mM)
followed by IGF-I (100 ng/ml) stimulation for 10 min. This has
been shown to activate Nox4 enzymatic activity (9). The com-
plexeswere immunoprecipitated fromcell lysates using an anti-
Nox4 antibody (1:500 dilution). Control immune complexes
were precipitated using lysates prepared from the cells cultured
using the same conditions and precipitated with a nonimmune
IgG. The immune complex was released using 50 l of SDS
buffer (20 mM Tris, pH 7.5, 50 mM NaCl, 2% SDS) and a 3-h
incubation at room temperature. To detect Src oxidation, non-
oxidized Src (10g of IP)was incubatedwithNox4 complex (10
g of IP) in 500 l of 50 mM phosphate buffer (pH 7.0, 1 mM
EGTA, 150 mM sucrose, and 100 M NADPH) for 1 h at 30 °C.
After extensive washing with radioimmunoprecipitation assay
buffer, Src was released from the immune complexes using
12% SDS. The above procedures were completed using
anaerobic conditions. Src oxidation was measured using a
modified OxyBlotTM protein detection kit (Millipore, Bil-
lerica, MA) as described previously (9).
After immunoprecipitating with an anti-SHPS-1 antibody,
the immune complex was released using 50 l of SDS buffer
and a 3-h incubation at room temperature. 500 l of the
above-mentioned phosphate buffer was added, and hydro-
gen peroxide was measured using an Amplex red hydrogen
peroxide assay kit (Invitrogen) by following the manufactur-
er’s instructions.
Animal Preparations andTreatments—Animalmaintenance
conformed to the U.S. National Institutes of Health Guide for
the Care and Use of Laboratory Animals. Hyperglycemia was
induced in C57/B6 mice (Taconic, Hudson, NY) using the low
dose streptozotocin protocol previously described (20). Briefly,
after withdrawal of food for 4 h, the mice were injected intra-
peritoneally with streptozotocin (50mg/kg) (n 72) daily for 5
days. Blood glucose levels were checked, and mice that had
serum glucose concentrations 250 mg/dl were considered
diabetic. They were maintained for 2 weeks before any treat-
ment. During that time, they maintained normal activity and
food intake, and no insulin injections were required. The
DVNI-containing peptide (n  24) (10 mg/kg) or the control
peptide (n 24) (10mg/kg) was administered intraperitoneally
daily for 2 days (24 h and 30 min before sacrifice). IGF-I (1
mg/kg) was administered intraperitoneally 15 min (n  24)
before sacrifice when signal transduction was being assessed
and 24 h (n  12) before sacrifice when measuring Ki67
staining.
Preparation of Aortas for Analysis—The mice were eutha-
nized by injectingNembutal (100mg/kg intraperitoneally). The
thoracic aortas were harvested and placed into ice-cold PBS.
Connective tissue and endotheliumwere removed prior to pro-
tein extraction. The aortaswere homogenized in ice-cold buffer
(20 mM Tris, 150 mM sodium chloride, 2 mM EDTA, and 0.05%
Triton X-100, pH 7.4) using a glass tissue grinder, and the
lysates were centrifuged at 13,000  g for 15 min. Protein con-
centrations in the supernatant were measured using a BCA
assay (Thermo Scientific). Equal amounts of protein were used
in each analysis.
Immunohistochemistry—The aortas from mice were fixed
with 4% paraformaldehyde overnight, and paraffin-embedded
sections were prepared by the University of North Carolina
histology core facility. An immunohistochemistry paraffin pro-
tocol described previously (9) was followed to stain the Ki67
positive nuclei. A DAPI-containing mounting medium (Vector
Laboratories, Burlingame, CA) was used to stain the total
nuclei. The Ki67-positive nuclei and the total nuclei were
counted in the aortic ring and expressed as the percentage of
positive nuclei.
Cell Proliferation Assay—Assessment of VSMC proliferation
was performed as described previously (21). Briefly, the cells
were incubated with or without IGF-I (50 ng/ml) in serum-free
DMEM containing high glucose (25 mM) and 0.2% platelet-
poor plasma for 48 h, and the cell number in each well was
counted.
Statistical Analysis—The results that are shown in all of the
experiments are the representative of three separate experi-
ments and expressed as the means  S.E. The Student’s t test
was used to compare differences between control and one
treatment or control cells and one mutant for some in vitro
experiments. One- or two-way analysis of variance was
applied for all data obtained from in vivo studies or when
multiple treatments or multiple cell types were compared
using data from in vitro studies. p  0.05 was considered
statistically significant.
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RESULTS
Sustained Src Activation in Response to IGF-I Primarily
Occurs on the SHPS-1 Complex—Although Src activation is
required for mediating the IGF-I signaling response during
hyperglycemia (15), it is unknown whether IGF-I stimulates
sustained Src activation. This is important because sustained
Src activation has been linked to sustained MAP kinase activa-
tion and cell proliferation (22). Analysis of whole cell lysates
obtained at several time points showed that peak IGF-I-stimu-
lated Src activation was sustained for 3 h and had not declined
to base line after 6 h (Fig. 1A). Because our previous studies
showed that hyperglycemia induced the formation of a signal-
ing complex on the cytoplasmic domain (CD) of the scaffolding
protein SHPS-1 and that IGF-I stimulated Src recruitment to
that complex (13, 14), we determined whether Src recruitment
to SHPS-1 resulted in sustained activation. The results showed
that SHPS-1-associated Src activation was also sustained for at
least 6 h (Fig. 1B). In contrast, non-SHPS-1-associated Src acti-
vation was transient and declined after 1 min of IGF-I stimula-
tion (Fig. 1B). In addition, although IGF-I stimulated Src
recruitment to SHPS-1 (supplemental Fig. S1A), the total
amount of Src inwhole cell lysate was not significantly different
from SHPS-1 free cell lysate (supplemental Fig. S1B), indicating
that only a small amount of Src was recruited to the SHPS-1
FIGURE 1. IGF-I stimulates sustained Src activation which primarily occurs in the SHPS-1 complex. VSMC cultured in DMEM containing high glucose (25
mM) plus 10% FBS were serum-deprived for 16 h before treatment with IGF-I for the indicated times (A and B). A, cell lysates were immunoblotted (IB) with
anti-p419Src and Src antibodies. The value of each bar is the ratio of the mean value of the scanning units for p419Src divided by the value of Src. ** (p  0.01)
and *** (p  0.001) indicate significant differences between the individual time point and the basal level. B, cell lysates were immunoprecipitated with an
anti-SHPS-1 antibody. The immune complex (Pellet) and supernatant (Super.) were immunoblotted with an anti-p419Src antibody, respectively. To control for
loading, the blots were reprobed with anti-SHPS-1 and Src antibodies, respectively. The value of each bar is the ratio of the mean value of the scanning units
for pSrc divided by the scanning units of SHPS-1 or total Src, respectively. * (p  0.05), ** (p  0.01), and *** (p  0.001) indicate a significant difference between
the individual time point and the basal level. NS indicates no significant difference between the individual time point and the basal level. C, cells expressing WT
or cytoplasmic domain deleted ( CD) SHPS-1 were cultured in DMEM containing 25 mM glucose and serum-deprived for 16 h before treatment with IGF-I for
10 min. Cytoplasmic and membrane fractions were isolated following the procedure described under “Experimental Procedures.” Src was immunoprecipitated
with an anti-Src antibody. Oxidized Src levels were measured following the procedure described under “Experimental Procedures.” The lysates were also
immunoblotted with an anti-pY419Src antibody. To control for loading, the blot was reprobed with an anti-Src antibody. The figures are representative of three
independent experiments.
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complex after IGF-I stimulation. To confirm the importance of
SHPS-1 association, we compared Src oxidation and activation
in cells expressing full-length SHPS-1 and a SHPS-1 mutant in
which the CD had been deleted. The results showed that there
was a much greater increase in oxidized Src and Tyr-419 phos-
phorylation in response to IGF-I in cells expressing SHPS-1
with an intact CD (Fig. 1C).
Nox4 and Src Coassociate on SHPS-1—Nox4-derived ROS is
required for IGF-I-stimulated Src activation (9); however, it is
unclear whether ROS that is generated byNox4 acts inmultiple
cellular locations or whether it acts locally to activate Src.
Because ROS is highly reactive and short lived, it is likely to be
more effective if it is generated in close proximity to its target
protein(s). To determine whether Nox4-generated ROS could
directly oxidize Src, an in vitro oxidation assay was employed.
Nonoxidized Src (inactive) was oxidized when it was incubated
with the activated Nox4 enzymatic complex in vitro (Fig. 2A).
Control immune complexes that did not contain Nox4 showed
no Src oxidation. Our previous study showed that both Src and
Nox4 are recruited to the SHPS-1 complex in response to IGF-I
(14); therefore, we examined whether a Nox4/Src complex was
formed on SHPS-1. A double immunoprecipitation (IP) analy-
sis demonstrated the formation of a ternary complex following
IGF-I stimulation (Fig. 2B). Ternary complex formation could
not be detected when control IgG was used in the initial IP. To
determine whether this interaction was direct, we utilized an in
vitro binding assay. The results showed that Nox4 did not
directly bind to Src (Fig. 2C), suggesting that Nox4 associated
with Src via an intermediary protein(s) and that Src did not
directly recruit Nox4 to SHPS-1.
Nox4 Phosphotyrosine 491 Mediates Its Recruitment to
SHPS-1 in Response to IGF-I—To determine how Nox4 is
recruited to SHPS-1, we initially determined that Nox4 was
tyrosine-phosphorylated in response to IGF-I stimulation (Fig.
3A). To determine whether this facilitated a protein-protein
interaction that led to SHPS-1 recruitment, we analyzed the
potential SH2 binding sites in Nox4 using Net-Phos 2.0, a web-
based phosphorylation site prediction program. Six tyrosine
phosphorylation sites with high potential were detected.
Among them, Tyr-491 had the highest score (0.987), and its
flanking sequences showed a typical SH2 domain-binding
motif (YVNI) (supplemental Fig. S2A). We then utilized a cell-
permeable synthetic peptide containing the DVNI motif and
Nox4 flanking sequences to determine whether this altered
Nox4 recruitment to SHPS-1. Cell exposure to the peptide for
2 h inhibited IGF-I-stimulated Nox4/SHPS-1 association,
whereas a control peptide had no effect (Fig. 3B). To definitively
determine the significance of Tyr-491 phosphorylation, we
expressed a mutant form of Nox4 in which Tyr-491 was substi-
tuted with phenylalanine. WT Nox4 was used as a control.
Expression of Nox4 was equivalent in both cell types (supple-
mental Fig. S2B). Analysis of VSMCexpressing theNox4Y491F
mutant showed significant inhibition of IGF-I-stimulatedNox4
tyrosine phosphorylation (Fig. 3C). Importantly, IGF-I-induced
Nox4/SHPS-1 association was abolished in Nox4 Y491F-over-
expressing cells, indicating that Tyr-491 phosphorylation
mediates Nox4 recruitment to SHPS-1 after IGF-I stimulation
(Fig. 3D). In addition, p22phox was also present in the SHPS-1
complex after IGF-I stimulation in Nox4 WT-overexpressing
cells but absent in Nox4 Y491F-overexpressing cells (Fig. 3D).
Next we determined the effect of inhibiting Nox4 recruit-
ment to SHPS-1 on localized ROS generation. H2O2 generation
from the SHPS-1 complex was detected using an Amplex red
hydrogen peroxide assay kit in Nox4 WT-overexpressing cells
in response to IGF-I but not in Nox4 Y491F-overexpressing
cells, indicating that inhibition of Nox4 recruitment to SHPS-1
prevented localized ROS generation (Fig. 3E). To confirm this
result, an in vitro oxidation assaywas performed using the same
conditions. The results show that SHPS-1-localized ROS is able
to oxidize Src, and prevention of Nox4 recruitment to SHPS-1
prevents the increase in Src oxidation (Fig. 3F). Furthermore,
we examined IGF-I-stimulated Src oxidation and activation in
cells after inhibition ofNox4 recruitment. IGF-I-stimulated Src
oxidation, which is a prerequisite for Src activation (9), was
significantly impaired when Nox4 recruitment was prevented
(Fig. 3G). Predictably, IGF-I-stimulated Src activation was also
significantly impaired in Nox4 Y491F-overexpressing cells,
compared with WT Nox4-overexpressing cells (e.g., a 29  3%
versus a 105  14%, p  0.05) (Fig. 3H).
FIGURE 2. Nox4 and Src are colocalized on SHPS-1 but do not directly bind
to each other. A, the Nox4 in vitro oxidation assay was performed as
described under “Experimental Procedures.” For control of Src and Nox4
input, the immune complexes from Src or Nox4 IPs were immunoblotted (IB)
with an anti-Src or Nox4 antibody, respectively. DNP, 2,4-dinitrophenyl. B,
double IP was performed following the procedure described under “Experi-
mental Procedures.” The immune complexes released from Nox4 and Src IPs
were immunoblotted with an anti-SHPS-1 antibody. Nonimmune IgG was
served as control IgG (Ctrl IgG) in the first round IP. To control for Nox4 input,
the cell lysates were immunoblotted with an anti-Nox4 antibody. C, the in
vitro binding assay was performed following the procedure described under
“Experimental Procedures.” T, W, and E represent total Nox4 protein, wash
solution, and elute, respectively. The figures are representative of three inde-
pendent experiments.
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Grb2 Mediates Nox4 Recruitment to SHPS-1 in Response to
IGF-I—To determine the component of the SHPS-1 signaling
complex that mediated Nox4 recruitment, we focused on
known components that had a high probability of binding to the
Nox4 Y491 site. Because YNVI is a typical SH2 domain-binding
motif, we analyzed the two SH2 domain-containing compo-
nents in the SHPS-1 complex: SHP-2 and Grb2. Two forms of
Nox4 (WT and Y491F) were expressed using the TNT system.
This tyrosine-phosphorylated Nox4 (Fig. 4A) was prepared as
described under “Experimental Procedures” and used to inves-
FIGURE 3. Phosphorylation of tyrosine 491 mediates Nox4 recruitment to SHPS-1 in response to IGF-I. VSMC, VSMC expressing Nox4 wild type (Wt), Nox4
Y491F mutant, or LacZ were cultured in DMEM containing 25 mM glucose plus 10% FBS and serum-deprived for 16 h before IGF-I treatment for 10 min. A, cell
lysates were immunoprecipitated with an anti-Nox4 antibody and immunoblotted with an anti-Tyr(P)-99 antibody. To control for loading, the blot was
reprobed with an anti-Nox4 antibody. B, a peptide containing the DVNI sequence (10 g/ml) was incubated 2 h before IGF-I treatment. Cell lysates were
immunoprecipitated with an anti-Nox4 antibody and immunoblotted with an anti-SHPS-1 antibody. To control for loading, the blot was reprobed with an
anti-Nox4 antibody. The value of each bar is the ratio of the mean value of the scanning units for SHPS-1 divided by the scanning units of Nox4. *** (p  0.001)
indicates a significant difference between two treatments. NS indicates no significant difference between two treatments. C, cell lysates were immunoprecipi-
tated with an anti-Nox4 antibody and immunoblotted with an anti-Tyr(P)-99 antibody. To control for loading, the blot was reprobed with an anti-Nox4
antibody. D, cell lysates were immunoprecipitated with an anti-HA or p22phox antibody, respectively, and immunoblotted with an anti-SHPS-1 antibody. To
control for loading, the blots were reprobed with an anti-HA or anti-p22phox antibody, respectively. E, cell lysates were immunoprecipitated with an anti-SHPS-1
antibody. The immune complexes were used to measure H2O2 generation following a procedure described under “Experimental Procedures.” * (p  0.05)
indicates a significant difference between two treatments. F, cell lysates were immunoprecipitated with an anti-SHPS-1 antibody. The immune complexes were
used to perform an in vitro Src oxidation assay following the procedure described under “Experimental Procedures.” To control for Src loading, the blot was
probed with an anti-Src antibody. G, cell lysates were immunoprecipitated with an anti-Src antibody. Oxidized Src levels were measured following the
procedure described under “Experimental Procedures.” To control for Src input, the blot was reprobed with an anti-Src antibody. H, cell lysates were immu-
noblotted with anti-p419Src and Src antibodies. The figures are representative of three independent experiments. Ctrl, control; DNP, 2,4-dinitrophenyl.
Function of SHPS-1-localized Nox4
15646 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288 • NUMBER 22 • MAY 31, 2013
tigate its potential interactionwithGrb2 or SHP2. Grb2 but not
SHP2 bound to WT Nox4 but not to the Y491F mutant (Fig.
4B). To determine whether Grb2 mediated Nox4 recruitment
to SHPS-1 in the cells, we initially determined whether IGF-I
stimulated Nox4/Grb2 association. IGF-I stimulated Nox4/
Grb2 binding, and this was disrupted using a DVNI-containing
peptide (Fig. 4C). Consistently, IGF-I-stimulated Nox4/Grb2
binding was not detected in cells expressing the Nox4 Y491F
mutant (Fig. 4D). In addition, the increase of SHPS-1-associ-
ated pY419Src in the membrane faction was abolished in
response to IGF-I when Nox4 Y491F was overexpressed,
whereas non-SHPS-1-associated Src activation was still detect-
able, although it was attenuated (Fig. 4E). To further confirm
that Grb2 mediated Nox4 recruitment to SHPS-1, we utilized
VSMC expressing a Pyk2 Y881Fmutant that we had previously
shown eliminated Grb2 recruitment to SHPS-1 (19). IGF-I-
stimulated Nox4/SHPS-1 association was not detected in the
Pyk2 Y881F mutant cells (Fig. 4F).
To determine the effect of disruption of Nox4 recruitment to
SHPS-1 on downstream signaling, AKT and MAP kinase acti-
vation were analyzed. Significant attenuation of AKT (e.g.,
3.7  0.5-fold versus 7.8  1.1-fold versus 10.8  1.1-fold
increase, respectively) and MAP kinase activation (e.g., 1.9 
0.2-fold versus 3.4  0.5-fold versus 5.2  0.2-fold increase,
respectively) was detected in Nox4 Y491Fmutant cells as com-
pared with LacZ and WT Nox4 cells (Fig. 5, A and B). Consis-
tently, IGF-I-stimulated cell proliferation was significantly
impaired in Nox4 Y491F mutant cells (e.g., a 1.26  0.11-fold
increase, p  0.05), compared with cells expressing LacZ con-
trol vector (e.g., a 2.06  0.16-fold increase) (Fig. 5C), whereas
overexpression of WT Nox4 significantly increased IGF-I-
stimulated cell proliferation (e.g., a 2.50  0.12-fold increase,
FIGURE 4. Grb2 mediates Nox4 recruitment to SHPS-1 in response to IGF-I. VSMC expressing LacZ, Nox4 wild type (Wt), Nox4 Y491F mutant, Pyk2 wild type,
or Pyk2 Y881F mutant were cultured in DMEM containing 25 mM glucose plus 10% FBS and serum-deprived for 16 h before IGF-I treatment for 1 or 10 min. A
and B, the in vitro phosphorylation and binding assay were performed following the procedures described under “Experimental Procedures.” C, the DVNI
containing peptide (10 g/ml) was incubated for 2 h before IGF-I stimulation. Cell lysates were immunoprecipitated with an anti-Nox4 antibody and immu-
noblotted (IB) with an anti-Grb2 antibody. To control for loading, the blot was reprobed with an anti-Nox4 antibody. D, cell lysates were immunoprecipitated
with an anti-HA antibody and immunoblotted with an anti-Grb2 antibody. To control for loading, the blot was reprobed with an anti-HA antibody. E,
membrane fractions were isolated following the procedures described under “Experimental Procedures.” The fractions were immunoprecipitated with an
anti-SHPS-1 antibody. The immune complex (Pellet) and supernatant (Super.) were immunoblotted with an anti-p419Src antibody, respectively. To control for
loading, the blots were reprobed with anti-SHPS-1 and caveolin antibodies, respectively. F, cell lysates were immunoprecipitated with an anti-Nox4 antibody
and immunoblotted with an anti-SHPS-1 antibody. To control for loading, the blot was reprobed with an anti-Nox4 antibody. The figures are representative of
three independent experiments. Ctrl, control.
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p  0.05). These results clearly demonstrate that the recruit-
ment ofNox4 to SHPS-1 after IGF-I stimulation is a crucial step
in mediating IGF-I signal transduction and biological actions.
To understand why IGF-I-stimulated signaling and biological
actions were impaired in Nox4 Y491F mutant-expressing cells
compared with the LacZ cells, we examined the effect of over-
expression of Nox4 or the Nox4 Y491F mutant on the expres-
sion of endogenous Nox4. The results clearly showed that
endogenous Nox4 expression was significantly suppressed in
both cell types that overexpressed Nox4 (Fig. 5D).
Mitochondria-derived ROS Does Not Contribute to IGF-I-
stimulated Src Oxidation and Activation or to IGF-I Down-
stream Signaling—To exclude the possibility that mitochon-
drial derived ROS plays a role in Src oxidation and activation in
response to IGF-I, a mitochondrial targeted catalase was over-
expressed in VSMC (Fig. 6A). Overexpression of catalase spe-
cifically in mitochondria did not alter IGF-I stimulated Src,
MAPkinase, orAKTactivation (Fig. 6,B–D). Importantly, IGF-
I-stimulated cell proliferation was also not changed by overex-
pression of catalase in mitochondria (Fig. 6E). As an alternative
approach to prevent an increasedmitochondria-derived hydro-
gen peroxide, DIDS was used. Consistently, the results showed
that preincubation with DIDS did not affect IGF-I-stimulated
Src oxidation (supplemental Fig. S3A) and activation (supple-
mental Fig. S3B). In addition, IGF-I-stimulated AKT activation
and MAP kinase activation were also not affected when this
inhibitor was used (supplemental Fig. S3, C and D).
SHPS-1/Grb2/Nox4 Association in Vivo and Disruption of
This Association Alters IGF-I-stimulated Signaling and Cell
Proliferation—Because our previous study showed that hyper-
glycemia enhanced IGF-I-stimulated Src oxidation and activa-
tion inmice (9), the importance ofNox4 recruitment to SHPS-1
for optimal Src activation after IGF-I stimulation in vivo was
investigated in diabetic animals. Importantly, administration of
a synthetic peptide containing theDVNImotif but not a control
peptide disrupted IGF-I-induced association of Nox4/Grb2
and impaired the Nox4 recruitment to SHPS-1, thereby con-
firming that Grb2 mediates Nox4 recruitment to SHPS-1 in
vivo (Fig. 7A). Consistent with the in vitro results, disruption of
Nox4 recruitment to SHPS-1 using this peptide impaired IGF-
FIGURE 5. IGF-I signal transduction and biological actions are impaired in Nox4 Y491F mutant expressing cells. VSMC expressing LacZ or Nox4 wild type
(Wt) or Nox4 Y491F mutant were cultured as described under “Experimental Procedures” and serum-deprived for 16 h before IGF-I treatment for 10 min. A, cell
lysates were immunoblotted (IB) with anti-pAKT (S473) and AKT antibodies. B, cell lysates were immunoblotted with anti-pErk1/2 and Erk1/2 antibodies. The
value of each bar is the ratio of the mean value of the scanning units for pAKT or pErk1/2 divided by the value of total AKT or Erk1/2. * (p  0.05), ** (p  0.01),
and *** (p  0.001) indicate significant differences between two cell types. C, cell proliferation was determined as described under “Experimental Procedures.”
p  0.05 indicates significant differences between two cell types. D, cell lysates were immunoprecipitated with an anti-HA antibody. The supernatants were
immunoblotted with anti-Nox4 and -actin antibodies. The figures are representative of three independent experiments. Ctrl, control.
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I-stimulated Src oxidation (Fig. 7B) and SHPS-1-associated Src
activation (Fig. 7C), whereas the control peptide had no effect
(Fig. 7, B and C). Similarly, a DVNI-containing peptide abol-
ished the ability of IGF-I to stimulate MAP kinase activation
during hyperglycemia, but the control peptide had on effect
(Fig. 7D). To determine the biological significance of Nox4
recruitment, VSMC proliferation was determined using Ki67
staining of diabetic mouse aortas. The results showed that
IGF-I stimulated cell proliferation from 27.1  1.4 to 40.0 
0.8% (p  0.01) in diabetic mice, and this stimulation was
significantly impaired following exposure to the DVNI con-
taining peptide (from 19.8  1.3 to 21.5  1.1%, p was not
significant), whereas the control peptide had no effect on
IGF-I-stimulated cell proliferation (29.8  1.2 and 42.6 
2.2%, p  0.01) (Fig. 7E).
DISCUSSION
Our prior study showed that Nox4 enzymatic activity was
stimulated by hyperglycemia and that this increase was
required for IGF-I-stimulated Src activation and cell prolifera-
tion. However, the underlying mechanism by which Nox4-ac-
tivated Src leads to increased IGF-I-stimulated cell prolifera-
tion was not defined. In the present study, we demonstrate that
IGF-I stimulates Nox4 recruitment to the plasma membrane
scaffold protein, SHPS-1, which allows local ROS generation to
activate Src. Because both proteins are recruited to SHPS-1 for
a prolonged time period and they are in close proximity, this
allows Nox4-derived ROS to oxidize Src. Because Src oxidation
leads to increased enzymatic activity (9), their colocalization is
an important step in the molecular events leading to sustained
Src activation in response to IGF-I. Importantly, this sustained
activation occurred almost exclusively on the SHPS-1 scaffold
because abundant oxidized and activated Src could be coimmu-
noprecipitated with SHPS-1, but there was a minimal increase
in Src activation that could not be sustained (e.g., 1 min) in the
non-SHPS-1-associated subcellular fraction. Our present study
also revealed that Grb2 is the intermediary protein that recruits
Nox4 to SHPS-1. Disruption of Nox4 recruitment via either
preincubation with a peptide that disrupted Nox4/Grb2 asso-
ciated or overexpression of a Nox4 mutant that did not bind
Grb2 significantly impaired IGF-I-stimulated Src oxidation and
activation.
ROS, both superoxide and hydrogen peroxide, play vital roles
in regulating growth factor signal transduction and biological
functions. However, antioxidants that inhibit generalized
increases in ROS do not result in any beneficial effect on reduc-
ing disease risk (2) (3). This suggests that localized ROS gener-
ation may be more important for activating specific signaling
pathways and inducing pathophysiological changes. This con-
clusion is supported by Woo et al. (4), who showed that mem-
brane-localized inactivation of peroxiredoxin I via tyrosine
phosphorylation allowed the accumulation of Nox1-derived
H2O2 in the membrane fraction, thereby resulting in enhanced
tyrosine kinase receptor signaling. Because Nox1 and Nox4 are
the major isoforms in vascular smooth muscle cells (7) and
Nox4-derivedROShas been shown to be required for angioten-
sin II- (8) and IGF-I-stimulated Src activation (9), in this study
we focused onNox4. Although differential subcellular localiza-
tion of Nox4 has been suggested to mediate different cellular
functions (10, 12), only one study has identified a specific mol-
ecule, PTPB1, whose activity was altered in response to Nox4
colocalization. This change was linked to activation of EGF sig-
naling (10), but these results were only studied in vitro.
Our previous study using unbiased proteomic screening
showed that IGF-I stimulatesNox4 recruitment to phosphoryl-
ated SHPS-1, a transmembrane protein that serves as a scaffold
for signaling complex formation in response to IGF-I (13, 14).
IGF-induced Src activation occurs on this complex, and this is
required for activation of downstream signaling (15). Because
Nox4 derived ROS is responsible for Src oxidation (9), we
hypothesized that Nox4 recruitment to SHPS-1 in response to
IGF-I would allow localized ROS generation within the SHPS-1
complex. In support of this hypothesis, our in vitro oxidation
experiments clearly show that Nox4 oxidizes Src when they are
close proximity. In addition, our data demonstrate that deletion
of SHPS-1 CD inhibits Src oxidation and activation, suggesting
that Nox4 recruitment to the SHPS-1 CD is a prerequisite for
Src activation in response to IGF-I.
FIGURE 6. Mitochondrial derived ROS does not contribute to IGF-I-stimu-
lated Src activation and IGF-I downstream signaling. VSMC expressing
mitochondrial localized catalase (MC) or LacZ were cultured in DMEM con-
taining 25 mM glucose plus 10% FBS and serum-deprived for 16 h before IGF-I
treatment for 10 min. A, mitochondrial (MF) and cellular (CF) fractions were
isolated following a procedure of mitochondria purification described in the
Abcam website. The subcellular fractions were immunoblotted (IB) with
anti-HA and prohibitin antibodies. B, cell lysates were immunoblotted
with anti-p419Src and Src antibodies. C, cell lysates were immunoblotted
with anti-pAKT and AKT. D, cell lysates were immunoblotted with anti-
pErk1/2 and Erk1/2 antibodies. E, cell proliferation was determined as
described under “Experimental Procedures.” N.S. indicates no significant dif-
ference between two cell types. The figures are representative of three inde-
pendent experiments. Ctrl, control.
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Previous studies have shown that sustained Src activation is
essential for mediating optimal growth factor signal transduc-
tion and biological actions. For example, sustained Src activa-
tion is required for PDGF-stimulated human airway smooth
muscle cell migration (23), and sustained Src activation is the
essential for up-regulation of MAP kinase activity (24). Our
previous studies have shown that Src activation is required for
MAPkinase activation (15) and that sustainedMAPkinase acti-
vation is required for optimal cellmigration and proliferation in
response to IGF-I (13). In addition, free radical-stimulated con-
tinuous activation of Src during ischemia/reperfusion has been
reported in rat hippocampus (25), and oxidation of Src is a
prerequisite for Src activation in response to IGF-I (9). How-
ever, free radicals diffuse quickly. Therefore, themechanism by
which they function to regulate signal pathways has not been
defined. A recent study indicated that inactivation of peroxire-
doxin I by its tyrosine phosphorylation reduced ROS elimina-
tion, which allowed localizedH2O2 accumulation for cell signal
transduction (4). Unfortunately, no specific signaling pathway
or molecule was identified in their study. Based on our current
results, which show sustained activity of Src when it is associ-
ated with SHPS-1, we postulate that to maintain sustained Src
activation, the recruitment of Nox4 to SHPS-1 is required.
Nox4/Src colocalization on SHPS-1 is an important step in the
series of signaling events leading not only to sustained Src acti-
vation but also to increased VSMC proliferation. ER localiza-
tion of Nox4 has been shown to regulate EGF signaling via
oxidation and inactivation of PTP1B, which required colocal-
ization of Nox4 and PTP1B in the ER (10). However, that study
did not explore whether these two molecules directly bound to
each other or whether their association was mediated by an
intermediary protein(s). In contrast, our results identified a
specific protein, Grb2, that mediated Nox4/Src colocalization.
Importantly, our results were also confirmed in vivo in diabetic
mice.
In contrast to Src, the mechanism of Nox4 recruitment to
SHPS-1 has not been reported previously. To determine the
component of the SHPS-1 signaling complex that mediated
Nox4 recruitment, we focused on three SH2domain containing
proteins in this complex, Src, SHP-2, andGrb2. In vitro binding
assay results showed that Grb2 but not Src or SHP-2 could
directly bind to Nox4. Our results show that binding occurred
through an interaction between a phospho-YVNI motif in
Nox4 and a SH2 domain inGrb2. That Tyr-491 was the specific
phosphotyrosine that mediated Nox4 recruitment to SHPS-1
was shown by demonstrating that cells expressing a mutant
form of Nox4 (Y491F) or a cell-permeable peptide containing a
Tyr to Asp substitution at position 491, and the Nox4 flanking
sequence prevented Nox4/Grb2 association as well as Nox4
recruitment to SHPS-1. To confirm this result, we utilized cells
that expressing a Pyk2 Y881F mutant, because our previous
study had shown that Pyk2 mediates Grb2 recruitment to
SHPS-1 (19). As predicted, cells expressing this mutant had
attenuated Nox4 recruitment. Therefore, we conclude that
Grb2 mediates Nox4 recruitment to SHPS-1 in response to
IGF-I, which allows Nox4-derived ROS to oxidize SHPS-1-as-
sociated Src leading to its activation. The importance of this
interaction for IGF-I signaling and biological actions was
shown by demonstrating that disruption of Nox4 recruitment
to SHPS-1 not only inhibited IGF-I-stimulated Src oxidation
and activation as well as cell proliferation in vitro, but it also
impaired IGF-I signal transduction and biological actions in the
aorta of diabetic mice. Therefore, we conclude that Nox4
recruitment to SHPS-1 is an important step leading to IGF-I-
stimulated VSMC proliferation. Although ROS has been pro-
posed to mediate growth factor-stimulated signaling (26) and
NADPH oxidases were involved in PDGF-induced ROS gener-
ation (27), this is the first study to demonstrate, in vitro and in
vivo, how a growth factor, IGF-I, modulates ROS generation on
a specific molecular scaffold to mediate increased downstream
signaling and biological actions.
A previous study reported thatmitochondrial localizedNox4
is responsible for high glucose-induced ROS generation (11).
To specifically eliminate a mitochondrial source of H2O2, a
mitochondrial localized catalase was introduced into the
VSMC. Cells expressing this mutant showed no change in IGF-
I-stimulated Src activation or in IGF-I-stimulated downstream
signaling and biological actions. In addition, a mitochondrial
superoxide inhibitor had minimal or no effect on the ability of
IGF-I to enhance Src oxidation, and activation in VSMC
exposed to high glucose, consequently, had no effect on IGF-I-
stimulated downstream signaling. Similarly, overexpression of
catalase targeted to mitochondria had no effect on Nox4-de-
pendent EGFR signaling (10). In addition, a recent study dem-
onstrated that, in skeletal muscle, mitochondria did not modu-
late cellular superoxide, but NADPH oxidases were the major
contributors of ROS generation during skeletal muscle rest or
contraction (28). Nox4 has been detected in different subcellu-
lar locations, such as perinuclear vesicles (29), focal adhensions
(12), the nucleus (30), and plasmamembrane (31). It is possible
FIGURE 7. Disruption of Nox4 recruitment to SHPS-1 impairs IGF-I-stimulated Src oxidation, activation, MAPK activation, and cell proliferation in vivo.
The 8-week-old male C57/B6 mice were prepared as described under “Experimental Procedures.” Following induction of diabetes, the mice were maintained
for 2 weeks. Prior to sacrifice, 24 diabetic mice were injected twice (24 h and 30 min) (intraperitoneally) with a DNVI-containing peptide (DVNI) (10 mg/kg). 24
diabetic mice were injected twice with a control peptide (Ctrl) (10 mg/kg). 15 min before sacrifice, the mice were also injected with IGF-I (1 mg/kg, diluted in
PBS) or with PBS alone (Ctrl). Aortic extracts were prepared using the procedure described under “Experimental Procedures.” A, aortic extracts were immuno-
precipitated using an anti-Nox4 antibody and immunoblotted (IB) using anti-SHPS-1 and Grb2 antibodies. The blot was stripped and reprobed with an
anti-Nox4 antibody as a loading control. B, Src was immunoprecipitated with an anti-Src antibody. The Src protein oxidation level was measured following a
procedure described under “Experimental Procedures.” To control for Src input, the blot was reprobed with an anti-Src antibody. C, aortic extracts were
immunoprecipitated using an anti-SHPS-1 antibody and immunoblotted using an anti-p419Src antibody. The blot was reprobed with anti-SHPS-1 antibody as
a loading control. D, aortic extracts were immunoblotted using anti-pErk1/2 and Erk1/2 antibodies. The value of each bar is the ratio of the scanning units of the
pErk1/2 bands divided by the scanning units of Erk1/2 bands. E, the aortas were fixed with 4% paraformaldehyde overnight for preparation of paraffin-
embedded sections. After staining with an anti-Ki67 antibody and DAPI, the number of proliferating cells and the total nuclei in the each section (total 16
sections) were counted and expressed as the percentage of Ki67-positive nuclei. The mean values  S.E. from four mice per treatment group (four sections
measured per mouse) are shown graphically, and representative images are also shown. p  0.05 and p  0.01 indicate significant differences when the two
treatments were compared. NS indicates no significant difference between two treatments. The figures are representative of three independent experiments.
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that these examples represent cell type-specific responses and
differential responses to distinct stimuli. Our previous study
has shown that IGF-I stimulates Nox4 and p22 complex forma-
tion, leading to ROS generation and Src activation (9). The cur-
rent results show that this occurs at a specific site in the plasma
membrane (the SHPS-1 complex). This allows localized H2O2
generation within the plasma membrane, a site that is also a
major focus of Src localization (32). However, we cannot
exclude the possibility that superoxide is also produced in this
complex. Based on our current results, we conclude that
SHPS-1 localized Nox4-derived ROS, rather than mitochon-
drial or pancellular increases in Nox4-derived ROS, is critical
for mediating IGF-I signaling and biological actions. Further-
more, as pointed out by Toledano et al. (33), localized H2O2
production may be important for protecting the rest of the cell
from the unwanted effects of H2O2 production as well as pro-
viding an important mechanism for H2O2-dependent signal
termination. Therefore, there may be multiple reasons why
localized ROS generation is the predominant Nox4-dependent
signaling mechanism.
This study presents a novel mechanism by which IGF-I stim-
ulates andmaintains Src activation during hyperglycemia. IGF-
I-stimulated tyrosine phosphorylation of Nox4 creates a SH2-
binding site, leading to Grb2 association and colocalization of
Nox4 with Src on the SHPS-1 scaffold. SHPS-1-localized Nox4
oxidizes Src, leading to sustained Src activation and subsequent
downstream signaling. Diabetic mice were used to confirm
these occurrences in vivo. This study is the first report of an
underlying mechanism by which localized Nox4-derived ROS
mediates sustained Src oxidation and activation, IGF-I down-
stream signaling, and biological actions. The findings suggest
several novel approaches that could be developed to prevent
localized ROS generation in response to hyperglycemia and
thereby prevent the progression of atherosclerosis in diabetic
patients.
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